Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2025-12-24 @ 4:02 PM
NCT ID:
NCT02564666
Eligibility Criteria:
Inclusion Criteria:
* Patient who agrees voluntarily
* Patient with a diagnosis of HCC is receiving Sorafenib monotherapy.
* Child-Pugh class, A or B, ECOG PS 0\~2
* 20 years of age or older.
* Patient who can listen and speak Korean
Exclusion Criteria:
* lack of cognitive ability or any r psychiatric illness
* Patient who is receiving combination treatment of TACE or other HCC treatment with Sorafenib.
* A hearing-impaired patient.
* Patient who has accompanied other primary malignants tumor in other organs except for HCC.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
90 Years
Study:
NCT02564666
Study Brief:
Protocol Section:
NCT02564666